Hospital
Floyd Valley Healthcare
Floyd Valley Healthcare was paid $1.57M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoFLOYD VALLEY HEALTHCARE
LE MARS, IA 51031
LE MARS, IA 51031
33aNPI1326109315assigned 12/13/2006
33bProvider typeCritical Access Hospital
28Total paid$1.57M
24GClaims38,050
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Iowa
Rank by total paid#23 of 79
Median peer was paid$801K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,461 | $199K | |
| 2019 | 7,658 | $242K | |
| 2020 | 5,291 | $195K | |
| 2021 | 6,626 | $292K | |
| 2022 | 4,067 | $227K | |
| 2023 | 5,107 | $254K | |
| 2024incomplete | 2,840 | $159K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 3,377 | 2,796 | $380K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 19% | 4,632 | 4,120 | $293K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 18% | 4,510 | 1,134 | $287K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.2% | 595 | 460 | $97K |
| 80053 | Comprehensive metabolic panel | 6.0% | 3,309 | 2,955 | $94K |
| 36415 | Collection of venous blood by venipuncture | 4.5% | 6,903 | 5,599 | $70K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.7% | 4,238 | 3,737 | $58K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 430 | 350 | $33K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.0% | 721 | 235 | $31K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.4% | 633 | 384 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 439 | 363 | $22K |
| 84484 | 1.3% | 435 | 355 | $21K |
49 more codes
| 86140 | <1% | 808 | $16K | |
| 83605 | <1% | 295 | $14K | |
| 80305 | <1% | 1,559 | $13K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 77 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 33 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 469 | $8K |
| 71045 | Radiologic examination, chest; single view | <1% | 330 | $8K |
| 81001 | <1% | 774 | $7K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 134 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 246 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 128 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 195 | $6K |
| 80306 | <1% | 127 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 52 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 50 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 111 | $3K |
| 82077 | <1% | 99 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 222 | $3K |
| 83690 | <1% | 182 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 126 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 94 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 471 | $2K |
| 80061 | Lipid panel | <1% | 66 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 103 | $2K |
| 87081 | <1% | 176 | $2K | |
| 82150 | <1% | 148 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 81 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 201 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 19 | $1K |
| 84703 | <1% | 56 | $1K | |
| 83880 | <1% | 16 | $829.12 | |
| 83874 | <1% | 14 | $829.12 | |
| 74019 | <1% | 14 | $646.94 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 28 | $589.25 |
| 87486 | <1% | 19 | $572.88 | |
| 87581 | <1% | 19 | $572.88 | |
| 81003 | <1% | 42 | $274.62 | |
| 82550 | <1% | 33 | $261.53 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 16 | $258.40 |
| 82553 | <1% | 15 | $252.94 | |
| J2704 | Injection, propofol, 10 mg | <1% | 27 | $230.55 |
| 87807 | <1% | 25 | $226.36 | |
| 83735 | <1% | 14 | $212.18 | |
| 82728 | <1% | 12 | $210.74 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 26 | $180.92 |
| 85610 | <1% | 14 | $146.98 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 31 | $70.58 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14 | $53.51 |
| A9270 | Non-covered item or service | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRIEDENBACH, DARYL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Floyd Valley Healthcare | Le Mars, IA | $1.34M |
| Floyd Valley Healthcare | Le Mars, IA | $396K |
| Floyd Valley Healthcare | Le Mars, IA | $321K |
| Floyd Valley Hospital | Le Mars, IA | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.